Ann Hynes
Stock Analyst at Mizuho
(2.2)
# 851
Out of 5,329 analysts
273
Total ratings
61.49%
Success rate
15.69%
Average return
Main Sectors:
Name | Action | PT | Current | % Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
UNH UnitedHealth Group | Maintains: Outperform | 600 650 | 400.12 | 62.45% | 17 | Apr 9, 2025 | |
DGX Quest Diagnostics | Maintains: Outperform | 178 189 | 177.4 | 6.54% | 14 | Apr 9, 2025 | |
MOH Molina Healthcare | Maintains: Outperform | 376 400 | 313.73 | 27.5% | 8 | Apr 9, 2025 | |
MEDP Medpace Hldgs | Maintains: Outperform | 400 355 | 302.55 | 17.34% | 2 | Apr 9, 2025 | |
IQV IQVIA Hldgs | Maintains: Outperform | 242 210 | 151 | 39.07% | 11 | Apr 9, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 238 200 | 145.22 | 37.72% | 14 | Apr 9, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 305 316 | 256.12 | 23.38% | 8 | Apr 9, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 12 10 | 6.06 | 65.02% | 2 | Apr 9, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 455 505 | 408.73 | 23.55% | 4 | Apr 9, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 175 155 | 116.92 | 32.57% | 2 | Apr 9, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 70 76 | 69.4 | 9.51% | 10 | Apr 9, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 19 18 | 12.57 | 43.2% | 2 | Apr 9, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 48 37 | 22.77 | 62.49% | 10 | Mar 25, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 13 15 | 12.77 | 17.46% | 11 | Nov 19, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 110 120 | 145.35 | -17.44% | 8 | Nov 4, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 17 20 | 17.93 | 11.54% | 1 | Nov 4, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 28 | 21.57 | 29.81% | 1 | Aug 19, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Strong Buy | 118 130 | 145.35 | -10.56% | 14 | May 1, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 93 95 | 116 | -18.1% | 8 | Apr 25, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 370 385 | 335.25 | 14.84% | 10 | Mar 8, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 175 200 | 174.69 | 14.49% | 15 | Mar 6, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 242 268 | 1.88 | 14155.32% | 1 | Feb 23, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 450 505 | 706.56 | -28.53% | 17 | Feb 9, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 257 230 | 241.29 | -4.68% | 15 | Oct 31, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 325 275 | 342.92 | -19.81% | 19 | Oct 25, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 31 25 | 10.94 | 128.52% | 8 | Oct 10, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 48 50 | 22.47 | 122.52% | 2 | Jul 11, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 80 76 | 59.38 | 27.99% | 7 | Jul 11, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 174 192 | n/a | n/a | 10 | Jul 11, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 38 43 | n/a | n/a | 9 | May 16, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Buy | 450 510 | n/a | n/a | 5 | Dec 20, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 32 | n/a | n/a | 1 | Mar 2, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 82 0 | n/a | n/a | 2 | Jan 24, 2018 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 90 0 | n/a | n/a | 2 | Nov 9, 2017 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Neutral | 57 | 1.5 | 3700% | 1 | Sep 21, 2017 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | n/a | n/a | n/a | 2 | Jul 20, 2017 |